Top Markets
Coin of the day
GSK plc GSK plc

GSK plc

GSK
Rankning i aktier #9382
GSK plc is a global pharmaceutical and healthcare company, deeply involved in... GSK plc is a global pharmaceutical and healthcare company, deeply involved in the research, development, production, and commercialization of a diverse range of medicinal and wellness products. Its operations span the United Kingdom, the United States, and numerous other international markets. The company structures its operations across four primary divisions: Pharmaceuticals, Pharmaceutical R&D, Vaccines, and Consumer Healthcare. Within its Pharmaceuticals segment, GSK provides treatments addressing a wide array of therapeutic areas. These include respiratory conditions, HIV, immuno-inflammatory diseases, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital health, metabolic imbalances, bacterial infections, and dermatological issues. The Consumer Healthcare division offers products across categories such as wellness, oral hygiene, nutritional supplements, and skin health. These consumer offerings come in a variety of formats, including oral dosage forms (e.g., tablets, syrups, lozenges, gummies, soft chews, effervescents), topical applications (e.g., gels, creams, patches, lip balms), nasal sprays, and a comprehensive range of oral hygiene products (e.g., toothpastes, mouthwashes, denture care items), alongside other specialized formulations like infant drops and wipes. GSK actively engages in various collaborative ventures. Its collaboration agreements include partnerships with 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Additionally, the company maintains strategic alliances with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. Originally established in 1715, the company operated under the name GlaxoSmithKline plc until its rebranding to GSK plc in May 2022. Its corporate headquarters are situated in Brentford, United Kingdom.
Aktiekurs
$25.28
Senast synkroniserad: 2026-09-18
Marknadsvärde
$1.01B
Förändring (1 dag)
-2.29%
Förändring (1 år)
-37.84%
Land
GB
Handel GSK plc (GSK)

Kategori

P/B-tal för GSK plc (GSK)
P/B-tal per September 2026 TTM: 4.22
Enligt GSK plc senaste finansiella rapporter och aktiekurs är det aktuella P/B-talet (TTM) 4.22. I slutet av 2024 hade företaget ett P/B-tal på 4.02.
Historik för P/B-tal för GSK plc från 2000 till 2026
P/B-tal vid årets slut
År P/B-tal Ändra
2026 (TTM) 4.22 -6.46%
2025 4.51 12.39%
2024 4.02 -8.79%
2023 4.40 -19.38%
2022 5.46 58.21%
2021 3.45 -6.69%
2020 3.70 -37.66%
2019 5.93 -56.31%
2018 13.58 -101.77%
2017 -767.86 -1,506.98%
2016 54.57 420.72%
2015 10.48 -16.42%
2014 12.54 39.48%
2013 8.99 -1.42%
2012 9.12 22.53%
2011 7.44 29.83%
2010 5.73 6.13%
2009 5.40 -20.54%
2008 6.80 14.36%
2007 5.95 -10.28%
2006 6.63 -28.07%
2005 9.21 -6.90%
2004 9.90 -16.16%
2003 11.80 36.40%
2002 8.65 -22.90%
2001 11.22 -6.68%
2000 12.02 0.00%
P/B-tal för liknande företag eller konkurrenter
Företag P/B-tal Skillnad i P/B-tal Land
29.9692 610.39%
US
7.6479 81.29%
US
-78.0908 -1,951.06%
US
8.4776 100.95%
CH
8.5385 102.40%
US